ArticleBreast cancer research and treatment2018

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.

Anna Sofie Kappel Buhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.